Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

Roberto S Oliveri, Jørn Wetterslev, Christian Gluud

220 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) results in more than 600,000 deaths per year. Transarterial embolisation (TAE) and transarterial chemoembolisation (TACE) have become standard loco-regional treatments for unresectable HCC.
Original languageEnglish
JournalCochrane Database of Systematic Reviews
Issue number3
Pages (from-to)CD004787
ISSN1469-493X
DOIs
Publication statusPublished - 2011

Keywords

  • Antineoplastic Agents
  • Carcinoma, Hepatocellular
  • Chemoembolization, Therapeutic
  • Embolization, Therapeutic
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms

Fingerprint

Dive into the research topics of 'Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this